Science
AI drug discovery
Using models to find candidate drugs faster than lab screening allows.
What it is
AI-originated molecules have reached mid-stage clinical trials. For longevity specifically, the value is in exploring mechanisms too complex or too slow for conventional screening.
Key mechanisms and technologies
- Generative chemistry
- Virtual cell models
- Phenomics
- Target identification
Published LONGEFI developments are listed chronologically in the News archive.